EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale

Christian Rummey iD, Jennifer M Farmer, David R Lynch iD

Annals of Clinical and Translational Neurology · 2026-02 · 13 (2) · 393-398

DOI: 10.1002/acn3.70239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 26.11.2025. Verfasst von Christian Rummey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Data Science GmbH, Basel, Switzerland. Hauptthemen laut MEDLINE: Friedreich Ataxia, Placebo Effect, Severity of Illness Index, Outcome Assessment, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Friedreich's Ataxia Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The placebo response in clinical trials in ataxias complicates outcome interpretation and potentially obscures genuine treatment effects. We analyzed placebo group data from past trials in Friedreich Ataxia and observed notable responses in appendicular items, in contrast to minimal changes in axial function, as measured by respective subscores of the modified Friedreich Ataxia Rating Scale (mFARS). The effect increased with the number of consecutive tests, shorter testing intervals, and older group ages. This has implications for trial design and endpoint selection, thus strengthening the utility of the Upright Stability Score (USS), a sub‐score of mFARS, as an independent measure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Friedreich AtaxiaPlacebo EffectSeverity of Illness IndexOutcome Assessment, Health CareHumansAdultMaleFemaleMiddle AgedYoung AdultAdolescent

Stichwörter der Autor:innen

ataxiaclinical trialsplacebo effectrating scales

Autor:innen und Institutionen

  • Clinical Data Science GmbH, Basel, Switzerland.
  • Friedreich's Ataxia Research Alliance, Downingtown, Pennsylvania, USA.
  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Christian Rummey, David R Lynch

Förderung

  • Friedreich's Ataxia Research Alliance

Zitieren

APA

Rummey, C., Farmer, J. M., & Lynch, D. R. (2026). Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale. Annals of Clinical and Translational Neurology, 13(2), 393-398. https://doi.org/10.1002/acn3.70239

Vancouver

Rummey C, Farmer JM, Lynch DR. Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale. Annals of Clinical and Translational Neurology. 2026;13(2):393-398. doi:10.1002/acn3.70239

BibTeX
@article{Rummey2026,
  author = {Rummey, Christian and Farmer, Jennifer M and Lynch, David R},
  title = {Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {393--398},
  doi = {10.1002/acn3.70239}
}
Kostenlos starten →